Gerhard Armauer Hansen that the leprosy acts of 1877 and 1885 were passed, leading to a steady decline of the disease in Norway from 1,800 known cases in 1875 to just 575 cases in 1901. His distinguished work was recognized at the International Leprosy Congress held at Bergen in 1909. Hansen had suffered from syphilis since the 1860s but died of heart disease. He was an atheist. Gerhard Armauer Hansen Gerhard Henrik Armauer Hansen (29 July 1841 – 12 February 1912) was a Norwegian physician, remembered for his identification of the bacterium "Mycobacterium leprae" in 1873 as the causative agent of leprosy. Hansen
Biomarker (medicine) a blood count, there are numerous novel biomarkers used in the various medical specialties. Currently, intensive work is taking place on the discovery and development of innovative and more effective biomarkers. These "new" biomarkers have become the basis for preventive medicine, meaning medicine that recognises diseases or the risk of disease early, and takes specific countermeasures to prevent the development of disease. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes. The "classic" biomarker in medicine is a